NCT00642954
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
Clinical trial condition
Blood Protein Disorders
Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.
3,045 public trials
568 recruiting studies
Blood Protein Disorders trial results
NCT02852837
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Beijing, China
- Hangzhou, China
- Shanghai, China
- Suzhou, China
NCT01155583
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT03344328
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chemotherapy Induced Peripheral Neuropathy, +13 more
- Locations
-
- CHU Clermont-Ferrand Clermont-Ferrand, France
NCT01102426
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- 1107 Tuscaloosa, Alabama, United States
- 1103 Los Angeles, California, United States
- 1105 Jacksonville, Florida, United States
- 1102 New York, United States
NCT02335983
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Research Site Bakersfield, California, United States
- CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States
- Research Site Burbank, California, United States
- Providence Saint Joseph Medical Center Burbank, California, United States
NCT04236063
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- University Malaya Kuala Lumpur, Malaysia
NCT01258998
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +82 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00966693
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)
NCT00422799
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States